Dr. Kalia is a Transplant Hepatologist who joined Montefiore Medical Center in 2009. Dr. Kalia received his medical education at the New York College of Osteopathic Medicine in Old Westbury, and then took four years of Internal Medicine Residency, the first three at UMDNJ in Newark and the next as a Chief Resident at the East Orange VA. He completed a Transplant Hepatology Fellowship at Mount Sinai Medical Center in New York City, and Gastroenterology Fellowship at UMDNJ-New Jersey Medical School, Newark NJ.
Dr. Kalia's clinical and research interests include NAFLD, Hepatitis B, complications of end stage liver disease and liver transplantation.
- Kalia H, Lopez PM, Martin P. Treatment of HCV in patients with renal failure. Arch Med Res. 2007 Aug;38(6):628-33. Review.
- Kalia H, Fabrizi F, Martin P. Hepatitis B virus and renal transplantation. Transplant Rev (Orlando). 2011 Jul;25(3):102-9
- Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF. Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir. Aliment Pharmacol Ther. 2014 Jan;39(2):209-16.
- Edelman D, Kalia H, Delio M, Alani M, Krishnamurthy K, Abd M, Auton A, Wang T, Wolkoff AW, Morrow BE. Genetic analysis of nonalcoholic fatty liver disease within a Caribbean-Hispanic population. Mol Genet Genomic Med. 2015 Aug 11;3(6):558-69. doi: 10.1002/mgg3.168. eCollection 2015 Nov.
Kalia HS, Gaglio PJ. The Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities. Clin Liver Dis. 2016 May;20(2):215-24. doi: 10.1016/j.cld.2015.10.005. Epub 2016 Feb 17. Review.PMID: 27063265
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.